slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 100,591-100,620
Pages 3,953
Rows per page 30
Component
100,591-100,620 of 118,578
32
The slide uses a combination of a data table, a biological mechanism diagram, and a summary of clinical validation to support the therapeutic thesis.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
36
Uses a Venn-like diagram to show genetic overlap between asthma and other conditions (COPD, eczema, neuro-inflammation, urticaria) to drive specific R&D strategies.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
37
Uses a bell curve distribution to illustrate the selection strategy for cases and controls.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
01
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
07
The slide uses a timeline-like bar to indicate the current development stage (IND-enabling) for two specific molecules.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
09
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
10
The slide uses a two-column layout to present the value proposition of the platform.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
13
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
03
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The slide uses a circular diagram to represent the AI-driven feedback loop between wet-lab data generation and model training.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
06
The slide illustrates a process flow from target antigen to AI-designed antibodies.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The slide uses a circular process diagram to link AI design with wet-lab validation.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
02
The slide features a lifestyle image on the left and the company logo and mission statement on the right.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Humble Origins1 hit
06
a.k.a. Brands | Investor Presentation Deck | 14 slidesa.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Early StrugglesLoop · Cost Of Inaction1 hit
07
The slide uses a collage of lifestyle photography to establish brand identity alongside key business facts.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
09
The slide uses a collage of lifestyle photography and store imagery to establish brand identity.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
10
The slide serves as a brand profile/context slide for a company called mnml.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
01
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Setup1 hit
05
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Evidence1 hit
10
The slide uses a structured layout to present clinical outcomes alongside a study overview box.Alkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · EvidenceLoop · Voice Of Customer1 hit
19
The radar chart represents a multi-dimensional optimization framework for drug development.Alkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
25
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
29
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Resolution1 hit
01
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
07
The slide uses a map to show regional prevalence and a nested circle diagram to show the funnel from total infected to treated patients.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a process-oriented flow diagram to explain the therapeutic strategy.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
10
The slide highlights the mechanism of action and key benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
23
The slide outlines a multi-part clinical trial structure with specific cohort sizes and dosing progression.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
25
The slide includes a financial disclaimer regarding cash balance and burn.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
01
argenx SE | Investor Conference Presentation Deck | 27 slidesargenx SE | Investor Conference Presentation Deck | 27 slides · argenx
Conference presentation Investor relations Beat · Humble Origins1 hit